Developing Digital Medicines And Digital Therapeutics: Five Steps For Success

The future of healthcare is changing. Thanks to digital medicines and digital therapeutics, patients have been empowered to participate in—and influence—their treatment, health, and well-being in clinical trials. Compared to traditional medicine, these new technologies have proven to support various stages of the healthcare journey and have been noted to address previously unmet needs. In addition, the technologies have also bridged gaps in the market.

Despite the excitement surrounding the convergence of software and healthcare and the possible opportunities and developments from these explorations, new challenges arise from the regulatory and reimbursement landscape.

Digital medicine and DTx development and commercialization will require careful planning. Download this checklist to access five key steps for ensuring regulatory requirements and commercial goals are integrated into a cohesive go-to-market strategy that addresses barriers to uptake and drives adoption.